Aptevo Therapeutics Inc. (NASDAQ:APVO) People

Aptevo Therapeutics Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anatolio B Cruz III
Other companies: Graf Acquisition Corp IV (Director · May 20, 2021 – May 20, 2021 · Past); Scripps Networks Interactive Inc (CLO & Corporate Secretary · Jul 1, 2008 – Aug 14, 2012 · Past); E.W. Scripps Company (The) (EVP & General Counsel · Feb 15, 2006 – Jul 1, 2008 · Past)
Director · Jul 15, 2016 – Jul 15, 2016 · Past
Marvin L. White
Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Jun 1, 2010); CoLucid Pharmaceuticals Inc (Director · Jul 9, 2015 – Mar 1, 2017 · Past); Washington Prime Group Inc (Director · May 8, 2014 – Aug 4, 2014 · Past)
Executive Chair · Since at least Jul 29, 2016
Fuad El-Hibri
Other companies: Emergent BioSolutions Inc. (Director · Nov 14, 2006 – Dec 3, 2021 · Past)
Director · Aug 1, 2016 – Dec 3, 2021 · Past
John E. Niederhuber
Other companies: Emergent BioSolutions Inc. (Director · Aug 23, 2010 – May 18, 2016 · Past)
Lead Independent Director · Since at least Aug 1, 2016
Robert Kramer
Other companies: Emergent BioSolutions Inc. (President and CEO, Director · May 31, 2013 – Jun 9, 2023 · Past)
President, Director · Jul 15, 2016 – Jul 15, 2016 · Past
Zsolt Harsanyi
Other companies: Emergent BioSolutions Inc. (Independent Director, Chairman of the Board · Since at least Nov 14, 2006)
Director · Since at least Jul 15, 2016
Barbara Lopez KunzDirector · Since at least Aug 1, 2016
Daniel J. Abdun-NabiDirector · Since at least Jul 17, 2025
Daphne TaylorSVP, CFO · Since at least Mar 3, 2023
Dirk HuebnerSenior Vice President and Chief Medical Officer · Since at least Jul 1, 2025
Eric M BurtDirector · Jul 15, 2016 – Jul 15, 2016 · Past
Grady Grant IIIDirector · Since at least Aug 1, 2016
Jeff LamothePresident and Chief Executive Officer · Since at least Aug 10, 2026
Jeffrey G LamothePresident and CEO, Director · Since at least Jul 29, 2016
Mary J. JanatpourSenior Vice President and Chief Scientific Officer · Since May 28, 2026
Michael AdelmanSVP, Commercial Operations · Nov 1, 2019 – Feb 18, 2020 · Past
Michael DarlingDirector · Jul 15, 2016 – Jul 15, 2016 · Past
Miriam Weber MillerVice President, Investor Relations and Corporate Communications · Since at least Oct 26, 2026
Scott C StromattChief Medical Officer and SVP · Jul 29, 2016 – Feb 28, 2019 · Past
SoYoung KwonSenior Vice President and General Counsel, Business Development and Corporate Affairs · Since at least May 24, 2021